Processing

Please wait...

Settings

Settings

Goto Application

1. EP2405940 - ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS

Office
European Patent Office
Application Number 10706731
Application Date 19.02.2010
Publication Number 2405940
Publication Date 18.01.2012
Publication Kind B1
IPC
C07K 16/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
12against material from bacteria
A61K 39/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
A61P 31/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
CPC
A61K 2039/505
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
505comprising antibodies
A61P 31/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
C07K 16/1282
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
12against material from bacteria
1267from Gram-positive bacteria
1282from Clostridium (G)
C07K 2317/20
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
2317Immunoglobulins specific features
20characterized by taxonomic origin
Applicants SEC DEP FOR HEALTH AND SOCIAL CARE
MICROPHARM LTD
Inventors SHONE CLIFFORD
LANDON JOHN
Designated States
Priority Data 0902851 20.02.2009 GB
0916153 15.09.2009 GB
Title
(DE) ANTIKÖRPER GEGEN CLOSTRIDIUM DIFFICILE TOXINE
(EN) ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS
(FR) ANTICORPS CONTRE LES TOXINES DE CLOSTRIDIUM DIFFICILE
Abstract
(EN) The present invention provides an antibody composition comprising ovine antibodies, for use in the prevention or treatment of C. difficile infection wherein the antibodies bind to a C. difficile toxin.
(FR) La présente invention concerne une composition d'anticorps comprenant des anticorps ovins, pour utilisation dans la prévention ou le traitement d'une infection par C. difficile caractérisée en ce que les anticorps se lient à une toxine de C. difficile.